Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2-methoxymethyl-2-hydroxymethyl-1-azabicyclo[2,2,2]octan-3-one

EU orphan designation number: EU/3/10/742   
Active ingredient: 2-methoxymethyl-2-hydroxymethyl-1-azabicyclo[2,2,2]octan-3-one
Indication: Treatment of acute myeloid leukaemia
Sponsor: Aprea AB
Karolinska Institutet Science Park, Nobels väg 3, SE-171 65 Solna, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/06/2010 Centralised Orphan - Designation EMEA/OD/147/09 (2010)3908 of 10/06/2010